Serum adiponectin levels in obese type 2 diabetic patients with diabetic retinopathy
Journal Title: Офтальмологический журнал - Year 2017, Vol 0, Issue 5
Abstract
Background. Diabetic retinopathy (DR) is one of the main complications of diabetes mellitus, the main cause of irreversible blindness in patients of working age in industrialized countries, has a high incidence rates and refers to neovascular eye diseases. At the present time, additional factors that affect the sensitivity to chronic hyperglycemia, the formation of microvascular complications, in particular, DR, include obesity and obesity-associated hormones of adipose tissue (adipokines: leptin, adiponectin, resistin, etc.). Purpose. To investigate the serum adiponectin levels in patients at different stages of DR in type 2 diabetes mellitus (T2DM) and obesity. Material and Methods. Study involved 99 patients, divided into 2 groups. The 1-st group (control group) consisted of 23 persons with obesity without T2DM (both male and female subjects; mean age, 57.03 ± 4.91 years), the 2-nd group consisted of 76 patients with T2DM, obesity and DR (both male and female subjects; mean age, 59.98 ± 4.17 years; mean duration of diabetes, 10.01 ± 2.81 years; mean glycated hemoglobin (HbA1C) level, 10.94 ± 2.08%), subdivided into 3 subgroups: with minimal and mild non-proliferative DR, with moderate to severe non-proliferative DR, with proliferative DR. The concentration of serum adiponectin was determined by ELISA kit. Statistical analysis included one- and two-factor analysis of variance. Results. Patients with mild non-proliferative DR had somewhat lower (worst) adiponectin levels among patients aged 60 and below with DM subcompensation. The lowest serum adiponectin levels were common for moderate to severe non-proliferative DR among T2DM patients aged above 60 with duration of diabetes of 10 years or less and with T2DM compensation. Among T2DM patients with proliferative DR, the worst serum adiponectin levels were common for T2DM patients aged 60 and below with duration of diabetes of less than 10 years and with T2DM compensation. Considering statistic values of serum adiponectin levels for this stage, it should be noted that, for conditionally combined proliferative DR with severe and moderate DR, statistically significant changes (р=0.007) consisted in the decreased serum adiponectin levels in T2DM compensation. Conclusions. Minimal and mild non-proliferative DR is characterized by a significant lower serum adiponectin level compared with the subsequent stages in subcompensation of T2DM.
Authors and Affiliations
N. Malachkova, M. Kyryliuk, I. Komarovska
Keywords
Related Articles
- EP ID EP251725
- DOI -
- Views 83
- Downloads 0
Assessing OCTA changes in morphology and structure of retinal microvascular bed in patients with exudative AMD
Background: Optical coherence tomography angiography (OCTA) enables measuring characteristics of the retinal microvascular bed such as vascular plexus density and foveal avascular zone (FAZ) area. Purpose: To assess the...
Cranial nerve III and/or VI function abnormalities associated with active herpesvirus infection: Clinical experience and literature review
Background: The field of oculomotor abnormalities (OMA) is of clinical and social importance. There is a group of OMA of unknown etiology. Purpose: To investigate the presence of DNA of herpesviruses venous blood of pat...
Outcomes of accelerated corneal collagen cross-linking in keratoconus
Keratoconus (KC) is a degenerative noninflammatory disease of the cornea which is characterized be structural changes in the cornea which leads to progressive thinning and bulging in the central and/or peripheral part of...
A two-stage laser surgery for fibroplastic changes of the vitreous humor
Background. Patients with profilerative vitreoretinopathy are performed vitrectomy which, however, is challenging in the presence of high visual function, transparent lenses, and single vitreoretinal adhesion bands as we...
Association between serum resistin level and diabetic retinopathy in obese patients with type 2 diabetes mellitus
Background: Diabetic retinopathy (DR) is a leading cause of blindness in developed countries. Factors like inadequate glycemic control, hypertonia, blood lipid disorder, and renal disease, are known to negatively affect...